Ify Oswunko

Company: Novo Nordisk

Job title: Chief Patient Officer, Rare Disease

Seminars:

Panel Discussion: Strategies for Enhancing Patient Retention in Rare Disease Trials 12:00 pm

Discussing the patient trial journey and key touchpoints for engagement that can positively impact retention Discussing the role of families and caregivers in supporting patient engagement and how to involve them in the retention strategy Sharing creative engagement methods & strategies that go beyond traditional approaches, to foster retentionRead more

day: Day Two PM

Building Trust & Overcoming Trial Recruitment & Retention Barriers in Diverse Communities: Case Study in Sickle Cell Disease 9:30 am

Approaches for developing trust between industry and healthcare providers and communities Co-developing tailored educational materials and resources that resonate with diverse patient populations Understanding the “long game” in maintaining ongoing engagement, fostering a supportive community where patients feel valued, informed, and empowered in their healthcare decisionRead more

day: Day Two AM